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mellitus among Chinese: the Beijing
longitudinal study of aging
Xue Cao1†, Zhe Tang2†, Jie Zhang1,3, Haibin Li1,3, Manjot Singh4, Fei Sun2, Xiaochun Li1,3, Changwei Li5,6,
Youxin Wang1,3, Xiuhua Guo1,3 and Deqiang Zheng1,3*
Abstract
Background: Some previous studies on different populations have yielded inconsistent findings with respect to the
relationship between levels of high-density lipoprotein cholesterol (HDL-C) and future type 2 diabetes mellitus
(T2DM) incidence. This study was designed to gain further insight into this relationship through a cohort study with
a 25-year follow-up duration.
Methods: In total, 1462 individuals that were 55 years of age or older and were free of T2DM at baseline were
enrolled in the present study. T2DM incidence among this study population was detected through self-reported
diagnoses or the concentration of fasting plasma glucose. The data were derived from nine surveys conducted
from 1992 to 2017. The correlation between HDL-C levels and the T2DM risk was assessed through Cox
proportional-hazards model and proportional hazards model for the sub-distribution with time-dependent variables.
Results: Over the follow-up period, 120 participants were newly diagnosed with new-onset T2DM. When research
participants were separated into four groups on the basis for quartiles of their levels of HDL-C measured at
baseline, and incidence of diabetes declined with higher baseline HDL-C levels at 12.60, 9.70, 5.38, and 5.22 per
1000 person-years, respectively. Adjusted hazard ratios (HRs) were 0.98 (95% confidence interval [CI]: 0.62–1.55), 0.48
(95% CI: 0.27–0.85) and 0.44 (95% CI: 0.25–0.80) for individuals with HDL-C levels within the 1.15–1.39, 1.40–1.69,
and ≥ 1.70 mmol/L ranges relative to participants with HDL-C levels < 1.15 mmol/L. Multiple sensitivity analyses
similarly revealed reduced risk of diabetes incidence with increased HDL-C levels. Incorporating the levels of HDL-C
into a multivariate model significantly enhanced the overall power of the predictive model (P values were 0.0296,
0.0011, respectively, for 5- and 10-year risk of diabetes).
Conclusions: Levels of HDL-C were independently and negatively associated with the risk of the new-onset T2DM
among middle-aged and elderly Chinese.
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Background
Diabetes mellitus is an increasingly widespread form of
chronic disease that affected an estimated 5.9 and 9.3% of
the global population in 2007 and 2019, respectively, [1]
and with incidence rates that forecast to further increase to
10.9% by 2045 [1, 2]. An estimated 11.2% of Chinese adults
currently suffer from diabetes, [3] despite the fact that type
2 diabetes mellitus (T2DM) is among the highly prevent-
able diseases [4]. Notably, T2DM is a key reason of global
mortality [5, 6]. Identifying reliable interventions targeting
modifiable risk factors is thus important to effectively con-
trolling and preventing this insidious disease [7].
Lower levels of high-density lipoprotein cholesterol
(HDL-C) are more prevalently detected within the context
of hyperglycemia, and as a result, metabolic syndrome-
related parameters including HDL-C levels are often con-
sidered when evaluating a given individual’s risk of T2DM
[8–10]. However, data pertaining to the link between
HDL-C levels and T2DM incidence have differed among
previous studies. In studies of American or European pop-
ulations, lower HDL-C levels have been reportedly linked
to higher risk of diabetes, [11–13] whereas no such rela-
tionship was observed in prior studies of Chinese popula-
tions [14, 15]. In our prior study of a Chinese population,
it was confirmed that increased ratios of triglyceride (TG)
to HDL-C (TG/HDL-C) were linked to an elevated risk of
T2DM incidence, [16] but whether this association is pri-
marily driven by reductions in HDL-C levels remains to
be determined. These inconsistencies have the potential to
be linked to the underreporting of T2DM incidence rates
and the extended interval between follow-up visits. Most
prior studies have primarily analyzed associations between
HDL-C levels measured at baseline and the future inci-
dence of diabetes, despite the fact HDL-C levels vary con-
tinuously with the passage of time. These factors may
result in studies that contradict one another or yield less
robust conclusions. As such, it is essential that a prospect-
ive study with multiple follow-up visits should be per-
formed to fully elucidate the link between levels of HDL-
C levels and the new-onset diabetes. As such, this current
study explored this association using data from a cohort
study with nine follow-up visits over a 25-year period, en-
abling us to assess the relationship between time-
dependent levels of HDL-C and the future T2DM risk.
Methods
Population
Data for the present study were derived from the Beijing
Longitudinal Study of Aging (BLSA), which evaluated
community-dwelling Chinese individuals who were 55
years and older as discussed in prior reports [16–18].
Briefly, the BLSA study population was selected with the
goal of ensuring accurate representation via a sampling
approach, namely three-stage stratification random-
clustering that was based upon the administrative dis-
trict, age-gender distributions, educational level, and
neighboring units, with administrative districts including
the Huairou County (extended suburb, mountain) and
Xuanwu District (urban), Daxing County (suburb, rural)
being selected from among the 18 administrative dis-
tricts of Beijing.
A total of 2101 representative study subjects com-
pleted initial baseline health exams in 1992 were en-
rolled in this study, with follow-up questionnaires being
completed in 1994, 1997, 2000, 2004, 2007, 2009, 2012,
and 2017, and with laboratory examinations being com-
pleted in 1992, 2000, 2009, 2012, and 2017. According
to the exclusion criteria of this current study, research
participants with a baseline diabetes diagnosis or base-
line concentration of fasting plasma glucose ≥7.0 mmol/
L were excluded (n = 246), as were individuals with miss-
ing baseline HDL-C measurements or other laboratory
examination data (n = 393). In total, 1462 participants
were included in the final analyzes. All BLSA partici-
pants had approved written aware consent, and the Eth-
ics Committee of Capital Medical University confirmed
this research (No. Z2019SY008), which was conducted
as per the Declaration of Helsinki.
Collection of data
A standardized stadiometer and weight-scale were
used to measure the weight of study subjects when
they were not wearing shoes and were only wearing
thin clothing. Participant body mass index (BMI)
was determined by weight (kg)/height squared (m2).
The blood pressure (BP) was assessed by analyzing
the right arm of each participant following a rest
period of a minimum of 5 min. All laboratory testing
was conducted on venous blood samples collected
following overnight fasting in the central laboratory,
Xuanwu Hospital, the Capital Medical University,
which conducted all quality control and correspond-
ing evaluations. Levels of TG, fasting plasma glucose
(FPG), total cholesterol (TC), HDL-C and low-
density lipoprotein cholesterol (LDL-C) were
assessed with an automated biochemical analyzer
(Hitachi 7150 Clinical/Chemistry Analyzer, HITA
CHI, Tokyo, Japan).
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Analyses of HDL-C levels and related covariates
Baseline levels of HDL-C were used to classify partici-
pants into four groups according to the first, the second
and the third quartiles by combining the maximum and
minimum values in the 1462 individuals included in this
current study, with ranges of 0.52–1.14 mmol/L, 1.15–
1.39 mmol/L, 1.40–1.69 mmol/L, and 1.70–5.03 mmol/L,
respectively. Individuals from Daxing County and
Huairou County were incorporated into a single group.
Education levels were separated into two groups: sec-
ondary or higher, and primary or lower. Job types in-
cluded heavy physical activity, light physical activity, and
mental activity. Alcohol intake was considered to be
mild, moderate, or heavy (< 50, 50–150, and > 150 mL/
day). With respect to smoking, individuals were catego-
rized as being ex-smokers, current smokers, or non-
smokers. Dietary information pertaining to the con-
sumption of eggs and staple foods was collected through
questionnaires. Regular exercise levels were classified as
low, moderate, or high (< 3, 3–10, and > 10 h/week, re-
spectively. Hypertension was defined based upon a self-
reported background of a hypertension diagnosis and/or
on a systolic BP ≥ 140mmHg and/or a diastolic BP ≥ 90
mmHg. Historical medical utilization of antihypertensive
medications and drugs for treating cardiovascular dis-
ease was also obtained.
Diagnosis of T2DM incidence
T2DM incidence among study subjects was detected
based upon self-reported diagnosis or an FPG level ≥ 7.0
mmol/L (126 mg/dl) [19, 20]. Research participants were
monitored for the incidence of diabetes or death from
baseline in 1992 to the end of the follow-up period by
2017. Mortality-related data were derived from family
member interviews and death certificates. The duration
of follow-up for each study subject was the period time
between baseline and the first to occur of diabetes inci-
dence death, or loss to follow-up.
Statistical analysis
Continuous variables were described as follows: means ±
standard deviation (SD), and a thorough comparison
were made via Kruskal-Wallis H tests. Categorical vari-
ables were displayed as frequencies with percentages and
were compared via χ2 test. Associations between the
levels of HDL-C and the incidence of T2DM were com-
pared utilizing multivariate Cox proportional-hazard
models. The proportional hazards for the sub-
distribution proposed by Fine and Gray (Fine-Gray
model) was also used to further assess the relationship
between the levels of HDL-C and the incidence of dia-
betes given the possible influence of death as competing
risk events [21]. Cox proportional-hazard model and
Fine-Gray model were implemented to quantify hazard
ratios (HRs) or sub-distribution HRs (SHRs) [22]. Age,
alcohol intake, smoking status, BMI, regular exercise,
staple food consumption, egg consumption, TG, LDL-C,
hypertension, antihypertensive drug use, and cardiovas-
cular medication use were treated as time-dependent
confounding variables, while gender, level of education,
residence, job types, and baseline FPG concentration
were analyzed as time-invariant variables in time-
dependent Cox proportional-hazards model and Fine-
Gray model. Four models with steps were utilized to as-
sess the relationship between the levels of HDL-C and
risk of future T2DM incidence. Mean values were ear-
marked to each class of HDL-C levels and were treated
as continuous variables when performing trend testing.
The relationship between the HDL-C levels and the
incidence of diabetes was additionally assessed using
Cox proportional-hazards model and Fine-Gray model
with baseline dynamic factor levels. Sensitivity analyses
were also performed wherein participants that were ≥ 75
years old in 1992 were excluded. The correlation be-
tween average HDL-C levels during follow-up and
T2DM HRs was examined via a restricted cubic spline
regression approach. Using the fully adjusted model,
subgroup analyses based upon gender were also con-
ducted, with HDL-C being used to separate study sub-
jects into two groups based upon baseline HDL-C levels
in 1992, using a value of 1.40 mmol/L as a cut-off for
separation. The analyses of Cox regression were then ex-
ecuted to explore the capability of HDL-C levels to esti-
mate T2DM incidence, with the curves of receiver
operating characteristic (ROC) being generated and the
discriminatory utility of these predictive models being
evaluated based upon the area under the ROC curve
(AUC).
SAS 9.4 (SAS Institute, NC, USA) and R 3.5.1 (R
Foundation for Statistical Computing, Vienna, Austria)
were implemented to accomplish statistical analyzes,




Over a median follow-up period of 8-years, 120 subjects
developed new-onset T2DM, while 566 were lost to
follow-up and 712 died. The mean baseline age of these
1462 participants was 68.81 ± 8.49 years. The schematic
of the current research was illustrated in Fig. 1A, while
participant characteristics summarized based upon
HDL-C quartiles were demonstrated in Table 1. Roughly
80, 53, and 79% of the participants exhibited a baseline
education level of primary or lower, were non-smokers,
and consumed mild levels of alcohol, respectively. Over
60% of individuals in all four HDL-C quartiles exhibited
hypertension at baseline, and those with greater levels of
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HDL-C exhibited lower BMI and TG levels values. Par-
ticipant characteristics after 8 years of follow-up (2000)
and at the last visit (2017) were respectively summarized
in Table S1 and Table S2 in the supplementary mate-
rials. Over the follow-up of 14,157.04 person-years, the
overall incidence of diabetes was 8.48/1000 person-years.
These incidences declined with rising baseline HDL-C
quartiles, with respective rates of which were 12.60, 9.70,
5.38, and 5.22 per 1000 person-years in each of these
quartiles. Unadjusted Kaplan-Meier survival estimates
for participants in these four baseline HDL-C quartiles
were shown in Fig. 1B, with significant differences
among groups as ascertained via log-rank test (P value <
0.001).
Associations between the HDL-C levels and T2DM risk
Time-dependent HDL-C levels were negatively associ-
ated with the risk of future T2DM incidence (Table 2).
After adjusting for gender, age, education, job type,
regular exercise, smoking status, alcohol intake, resi-
dence (Model I), BMI, hypertension, staple food
consumption and egg consumption (Model II), LDL-C,
TG, antihypertensive drug use, and cardiovascular medi-
cation use (Model III), and baseline FPG concentrations
(Model IV) in multivariate analyses, similar decreased
HRs were calculated with respect to the incidence of dia-
betes as a function of elevated levels of HDL-C across
different models. Adjusted HRs for individuals with
time-dependent levels of HDL-C in Q2 (1.15–1.39
mmol/L), Q3 (1.40–1.69 mmol/L) and Q4 (≥ 1.70 mmol/
L) were 0.98 (0.62–1.55), 0.48 (0.27–0.85) and 0.44
(0.25–0.80) relative to individuals in Q1 (< 1.15 mmol/L)
in Model IV. Therefore, the risks of diabetes incidence
for participants in Q3 and Q4 substantially declined
through roughly 50% relative to those in the lowest
HDL-C quartile. This trend towards reducing the T2DM
risk was significant for the classes with elevated levels of
HDL-C (P = 0.002), and SHRs yielded similar results
(Table 2). In Q2, Q3, and Q4, HDL-C levels were still
strongly correlated with the risk of diabetes, with SHRs
of 1.07 (0.68–1.67), 0.52 (0.29–0.92) and 0.52 (0.30–
0.91), respectively, relative to Q1 (Table 2).
Fig. 1 Flowchart demonstrating the participant selection process and survival curves corresponding to the four HDL-C quartiles. (A). Study
participant selection flowchart. (B). Kaplan–Meier curve. (C). Adjusted Cox regression survival curves used in Model IV
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Table 1 Baseline features of research participants









Age, year 68.15 ± 8.29 69.21 ± 8.18 69.26 ± 8.89 68.6 ± 8.54 0.279
Male, n (%) 207 (56.71) 178 (49.31) 176 (47.31) 172 (47.25) 0.032
Residence, n (%) 0.022
Urban 201 (55.07) 206 (57.06) 193 (51.88) 229 (62.91)
Rural 164 (45.93) 155 (42.94) 179 (48.12) 135 (37.09)
Educational level, n (%) 0.081
Secondary or higher 86 (23.56) 81 (22.44) 61 (16.40) 74 (20.33)
Primary or lower 279 (76.44) 280 (77.56) 311 (83.60) 290 (79.67)
Job types, n (%) 0.078
Mental activity 73 (20.0) 72 (19.9) 59 (15.9) 67 (18.4)
Light physical activity 93 (25.5) 98 (27.1) 116 (31.2) 127 (34.9)
Heavy physical activity 199 (54.5) 191 (52.9) 197 (53.0) 170 (46.7)
Alcohol intake, n (%) 0.040
Mild 39 (10.68) 42 (11.63) 46 (12.37) 60 (16.48)
Moderate 326 (89.32) 319 (88.37) 326 (87.63) 304 (83.52)
Heavy 39 (10.7) 42 (11.6) 46 (12.4) 60 (16.5)
Smoking status, n (%) 0.3810
Non-smoker 190 (52.1) 197 (54.6) 205 (55.1) 182 (50.0)
Ex-smokers 50 (13.7) 63 (17.5) 59 (15.9) 64 (17.6)
Current smokers 125 (34.2) 101 (28.0) 108 (29.0) 118 (32.4)
Staple food, g/day, n (%) 0.119
≤ 300 131 (35.9) 150 (41.6) 144 (38.7) 163 (44.8)
350–450 131 (35.9) 125 (34.6) 129 (34.7) 129 (35.4)
≥ 500 g 103 (28.2) 86 (23.8) 99 (26.6) 72 (19.8)
Egg consumption, a day, n (%) 0.026
0 59 (16.2) 67 (18.6) 52 (14.0) 48 (13.2)
1 200 (54.8) 205 (56.8) 212 (57.0) 184 (50.5)
> 1 106 (29.0) 89 (24.7) 108 (29.0) 132 (36.3)
Regular exercise, hours/week, n (%) 0.572
< 3 145 (39.73) 146 (40.44) 157 (42.2) 145 (39.84)
3–10 151 (41.37) 151 (41.83) 141 (37.90) 163 (44.78)
> 10 69 (18.90) 64 (17.73) 74 (19.89) 56 (15.38)
BMI (kg/m2) 23.9 ± 3.78 23.64 ± 3.84 22.75 ± 3.76 22.27 ± 3.85 < 0.001
TG (mmol/L) 1.74 ± 0.92 1.55 ± 0.72 1.29 ± 0.57 1.28 ± 0.65 < 0.001
LDL-C (mmol/L) 3.00 ± 0.95 3.17 ± 0.97 2.88 ± 0.99 2.89 ± 0.99 < 0.001
FPG (mmol/L) 5.06 ± 1.01 5.10 ± 1.01 5.19 ± 1.01 5.33 ± 0.84 0.003
Hypertension, n (%) 233 (63.8) 226 (62.6) 31 (62.1) 223 (61.3) 0.910
Antihypertensive drug, n (%) 58 (15.9) 52 (14.4) 52 (14.0) 45 (12.4) 0.595
CVD medication, n (%) 57 (15.6) 61 (16.9) 43 (11.6) 46 (12.6) 0.131
BMI, body mass index; CVD, cardiovascular disease; FPG, fasting plasma glucose; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides
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Sensitivity analyses
A negative association of baseline HDL-C with T2DM
incidence was also detected., and such that step eleva-
tion in HDL-C levels was correlated with reduced risks
of T2DM (Table 3). Under the fully-adjusted Model IV,
the HRs for the incidence of diabetes for individuals in
Q2, Q3, and Q4 were, respectively, 0.75 (0.48–1.18), 0.49
(0.28–0.85) and 0.44 (0.25–0.77). Considerable differ-
ences in survival probabilities and increasing trends for
adjusted survival curves were observed with increasing
HDL-C levels across these four quartiles (Fig. 1C).
Time-dependent Cox regression and Fine-Gray models
yielded consistent results when participants who were >
75 years old at baseline were excluded from these ana-
lyses (Fig. 2A). Restricted cubic spline Cox regression
analyses performed using average HDL-C levels during
follow-up for participants similarly revealed lower HRs
of diabetes with increased HDL-C levels (Fig. 2B). The
Table 2 Adjusted hazard ratios for incidence of T2DM by the groups of HDL-C levels in the analyses of regression with time-
dependent variables
HDL-C (mmol/L)
< 1.15 1.15–1.39 1.40–1.69 ≥ 1.70
No. of participants 365 361 372 364
No. of diabetes cases 46 35 20 19
Incidence/1000 person-years 12.60 9.70 5.38 5.22
Hazard ratio (95% confidence interval) P-value
Time-dependent Cox regression
I 1.00 0.96 (0.62–1.50) 0.46 (0.26–0.78) 0.37 (0.21–0.64) < 0.001
II 1.00 1.00 (0.64–1.56) 0.49 (0.28–0.85) 0.45 (0.26–0.78) 0.001
III 1.00 1.04 (0.66–1.64) 0.54 (0.31–0.95) 0.49 (0.28–0.88) 0.006
IV 1.00 0.98 (0.62–1.55) 0.48 (0.27–0.85) 0.44 (0.25–0.80) 0.002
Time-dependent Fine-Gray model
I 1.00 0.97 (0.63–1.50) 0.45 (0.26–0.76) 0.39 (0.23–0.67) < 0.001
II 1.00 1.03 (0.67–1.58) 0.48 (0.28–0.83) 0.48 (0.28–0.82) 0.002
III 1.00 1.10 (0.70–1.73) 0.56 (0.32–0.99) 0.56 (0.32–0.97) 0.014
IV 1.00 1.07 (0.68–1.67) 0.52 (0.29–0.92) 0.52 (0.30–0.91) 0.008
BMI, body mass index; FPG, fasting plasma glucose; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; TG, triglycerides
I: Adjustments were made for gender, age, education, smoking status, alcohol intake, regular exercise, residence and job type
II: Model I along with hypertension, BMI, consumptions of staple foods and eggs
III: Model II along with LDL-C, TG, antihypertensive drug and cardiovascular medication use
IV: Model III along with FPG
Table 3 Adjusted hazard ratios (95% confidence interval) of T2DM incidence conforming to baseline levels of HDL-C
Model HDL-C (mmol/L) P
value< 1.15 1.15–1.39 1.40–1.69 ≥ 1.70
Cox regression
I 1.00 0.76 (0.49–1.19) 0.44 (0.26–0.76) 0.39 (0.23–0.67) < 0.001
II 1.00 0.80 (0.51–1.25) 0.49 (0.29–0.84) 0.44 (0.25–0.77) 0.002
III 1.00 0.79 (0.51–1.25) 0.54 (0.31–0.94) 0.48 (0.27–0.84) 0.008
IV 1.00 0.75 (0.48–1.18) 0.49 (0.28–0.85) 0.44 (0.25–0.77) 0.004
Fine-Gray model
I 1.00 0.77 (0.50–1.19) 0.43 (0.26–0.72) 0.39 (0.23–0.67) < 0.001
II 1.00 0.82 (0.53–1.26) 0.47 (0.28–0.80) 0.45 (0.27–0.78) 0.003
III 1.00 0.82 (0.53–1.27) 0.53 (0.31–0.90) 0.49 (0.29–0.85) 0.009
IV 1.00 0.78 (0.50–1.22) 0.48 (0.28–0.82) 0.46 (0.27–0.79) 0.005
BMI, body mass index; FPG, fasting plasma glucose; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglycerides
I: Adjustments were made for gender, age, education, smoking status, alcohol intake, regular exercise, residence and job type
II: Model I along with hypertension, BMI, consumptions of staple foods and eggs
III: Model II along with LDL-C, TG, antihypertensive drug and cardiovascular medication
IV: Model III along with FPG
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subgroup analysis yielded similar results across different
gender, with HRs for men and women of 0.48 (0.25–
0.92), 0.49 (0.28–0.83), respectively (Fig. S1 in the sup-
plementary materials).
Assessment of the predictive utility of HDL-C levels
A univariate Cox proportional hazard model only in-
cluding levels of HDL-C was constructed which revealed
HDL-C levels to be a significant predictor of T2DM in-
cidence, with values of AUC at 0.717 (95% CI 0.620–
0.814) and 0.678 (95% CI 0.612–0.745) for 5- and 10-
year risk of diabetes incidence, respectively (Fig. 2C and
D). Furthermore, two Cox proportional hazard models
incorporating significant factors including age, BMI,
staple food consumption, HDL-C, and baseline FPG
(Model IV) and TG used in previous diabetes prediction
models, were built to examine the predictive utility of
HDL-C levels. The full multivariate model incorporating
HDL-C levels improved the AUC values from 0.698
(95% CI 0.606–0.791) and 0.714 (95% CI 0.650–0.779),
respectively, to 0.749 (95% CI 0.672–0.826) and 0.753
(95% CI 0.692–0.813) for 5- and 10-year diabetes inci-
dence, respectively (Fig. 2C and D). In addition, time-
dependent ROC curves differed significantly between the
full model and the model not incorporating HDL-C
levels (P values were 0.0296 and 0.0011, respectively).
Discussion
The results of this prospective analysis of community-
dwelling Chinese adults in Beijing revealed an inde-
pendent relationship between HDL-C and the risk of
T2DM incidence. This negative correlation remained
evident even when conducting multivariate competing
risk analyses wherein death was treated as a compet-
ing outcome. The link between HDL-C and the risk
of new-onset diabetes exhibited a dose-response rela-
tionship when treating HDL-C level as a continuous
variable, and the incorporation of HDL-C into multi-
variate predictive models improved the overall pre-
dictive performance of these models. As such, all
these data provide robust support for the conclusion
that HDL-C were negatively correlated with the risk
of future T2DM incidence.
These findings aligned well with prior evidence sup-
porting a link between the levels of HDL-C and the
future incidence of T2DM [11, 13, 23–25]. The
Fig. 2 Sensitivity analyses of the association between HDL-C levels and T2DM risk. (A). Relationships between the levels of HDL-C and the risk of
diabetes among individuals under the age of 75 (F-G: Fine-Gray model). (B). Associations between continuous levels of HDL-C and diabetes
incidence in terms of dose-response, with 95% confidence intervals being indicated with dashed lines. (C). ROC curves based upon time-
dependent Cox regression analyses used to predict 5-year risk. (D). ROC curves based upon time-dependent Cox regression analyses used to
predict 10-year risk
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Danish PREVENT study, which focused on a popula-
tion of individuals with an average age of 49 years
and without diabetes, determined that greater levels
of HDL-C were protective against the onset of T2DM
with an odds ratios (OR) and 95% CI of 0.55 (0.47–
0.64) [11]. In the ASCOT-BPLA trial analyzing pre-
dictors of T2DM incidence among 14,120 partici-
pants, an HR of 0.72 (95% CI, 0.58–0.89) was
reported for HDL-C levels increasing by one unit
[23]. One longitudinal research of individuals in Fra-
mingham Offspring research similarly detected a
negative relationship between HDL-C and T2DM in-
cidence, having an OR of 0.96 (95% CI, 0.95–0.98)
[25]. Two prior analyses conducted in China have
yielded inconsistent findings. In one case, an analysis
of a rural Chinese cohort observed no link between
the levels of HDL-C as well as T2DM incidence, with
an HR of 0.92 (95% CI, 0.70–1.19) in the group with
the levels higher than the third quartile relative to the
group with the levels less than the first quartile [14].
In the other case, a prospective analysis detected no
link between HDL-C and T2DM risk (OR = 0.460; P =
0.189) [15]. However, in both of these studies, sub-
jects were only evaluated at two follow-up time points
during which medical histories were taken and exami-
nations were completed, and these follow-up visits
were at relatively late time points, respectively, at 7
and 15 years. The potential underestimation of T2DM
development over such an extended interval may have
adversely impacted efforts to gauge the true link be-
tween HDL-C and the new-onset T2DM risks. Two
studies of Korean populations have yielded inconsist-
ent conclusions. In line with our findings, one pro-
spective cohort investigation on the basis of Korean
National Health Insurance System enrolling 19,475,
643 adults, with 5.13 years of the median follow-up
period, found that lower HDL-C levels (men: < 40 mg/
dL; women: < 50 mg/dL) to be correlated with a
greater risk of T2DM [26]. In contrast, a retrospective
cohort analysis of 5577 participants, during a 4-year
follow up period, detected no significant link between
these two variables, with an OR of 0.877 (95% CI,
0.753–1.021) for each one standard deviation increase
of HDL-C levels [27].
The majority for these prior analyses, including the
two studies of Chinese populations, primarily utilized
a single measurement of HDL-C levels rather than
adjusting for time-dynamic variables, thus potentially
yielding inconsistent results owing to fluctuations in
these levels as a function of time. In this present ana-
lysis, the HDL-C level was treated as a time-
dependent variable, and considered the possible ef-
fects of other time-varying confounders that can pos-
sibly impact T2DM risk in order to accurately assess
the correlation between HDL-C and the risk of future
incidence of diabetes. Moreover, mortality as a com-
peting event in order to decrease the bias associated
with the right-censored treating of non-terminal
events was processed. Importantly, analyses of this
current study confirmed a link between HDL-C levels
and the risk of diabetes incidence through both when
treating HDL-C levels as a time-dynamic variable and
when assessing these levels at baseline, confirming the
robustness of conclusions. Few studies to date have
explored the relationship between HDL-C levels and
the risk of new-onset diabetes through both time-
dependent and baseline analyses in a Chinese
population.
A range of mechanisms may explain the link be-
tween increased levels of HDL-C and reduced risk of
diabetes risk, including anti-inflammatory response
mechanisms, improved insulin secretion and the up-
take of glucose by the peripheral muscles [28–32].
One double-blinded placebo-controlled study observed
significant improvements in plasma glucose levels in
subjects that were intravenously administered recon-
stituted HDL-C (rHDL-C). Apolipoprotein (apo) A-I
is a key HDL-C component that can promote AMPK
pathway activation and thereby drive peripheral
muscle glucose uptake [28, 29]. A series of in vitro
analyses have provided experimental evidence for the
ability of HDL-C to prevent or reverse reductions in
insulin secretion associated with exposure to oxidized
LDL-C, and one randomized controlled trial found
that recombinant HDL infusion promoted AMPK
pathway activation in the skeletal muscle of individ-
uals with T2DM [29, 30]. In one analysis of rats and
humans, HDL particles were shown to neutralize β-
cell functional damage associated with oxidized LDL-
C exposure via the JNK pathway [31]. Another mouse
model study determined the link between lower HDL-
C and the decreased uptake of glucose by peripheral
skeletal muscle owing to a decrease in mitochondrial
respiratory function within these cells [32]. Some
prior publications have found that the protective im-
pact of HDL-C in the context of T2DM risk was
linked to changes in the function of pancreatic β-cell
cells [33]. Atherogenic dyslipidemia and associated in-
sulin resistance are thought to be driven in large part
by increased hepatic free fatty acid flux, [27] leading
to the liver-mediated secretion of particles containing
apo-B [34]. A case-control analysis exploring associa-
tions among vitamin D, IFG, and T2DM further de-
termined that HDL-C levels mediated 10.03% of the
effects associated with vitamin D in males, while the
ability of vitamin D levels to mediate the effects of
HDL-C-C on T2DM in this same context was less
evident [35].
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Strengths and limitations
This study has multiple important strengths. First, this
was a standardized and well-designed cohort study with
rigorous quality control, ensuring that the specimen of
middle-aged and elderly individuals in China was as rep-
resentative as possible. As such, conclusions in this study
are robust and informative. Second, repeated HDL-C
measurements in the study were treated as a time-
variant variable to overcome the bias of regression dilu-
tion, and ensure that were more accurately examining
the link between the levels of HDL-C and the future risk
of new-onset T2DM. Third, competitive risk analyses
were performed in which death was treated as a compet-
ing event to ensure that the conclusions were robust.
There are some limitations in this current study. For
one, a lack of 2 h post-load glucose testing or fasting
HbA1c measurements suggests that some cases may have
not been accurately diagnosed with T2DM. However,
T2DM incidence was identified based on both self-
reported diagnoses and fasting plasma glucose concen-
trations over a relatively short time period, such that the
overall effect of T2DM underdiagnosis on this current
study results can be decreased. Second, while this
present study collected some data pertaining to dietary
habits including the consumption of staple foods and
eggs in this study, more detailed dietary details were not
obtained. Although red wine intake was measured in this
study, few participants (1.30%) consumed this form of
alcohol, which was a luxury product in China in the
1990s. Third, by specifically focusing on middle-aged
and elder population in Beijing, it is unable to determine
whether the findings are applicable to other age groups
or populations of other ethnics. As such, additional epi-
demiological and experimental research will be essential
to deeper understand the link between HDL-C and the
future risk of diabetes incidence.
Conclusions
In conclusion, this study herein determined that the
levels of HDL-C were independently and negatively
linked to the risk of new-onset T2DM among middle-
aged and elderly Chinese. Increased HDL-C levels were
found to correlate with diminished T2DM risk over the
25-year follow-up period, suggesting that HDL-C levels
may influence glucose metabolism. These findings may
be of value by helping to guide the prevention of T2DM,
and thus underscore the utility of lipid profiles as indices
that can be used to predict diseases and to guide the de-
sign of clinical treatment plans.
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